Delivery Order SPE2DB25D7068-SPE2DB25FTWLH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count) under a firm fixed-price arrangement with a ceiling value of $1,297.75. This non-set-aside contract will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count) in a firm fixed price contract valued at $1,083.96, with an ultimate completion date of September 4, 2025. This non-set-aside competitive award was issued on September 3, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count) with a ceiling value of $1,291.52 under a firm fixed-price contract type. This delivery order, issued on April 23, 2025, with an ultimate completion date of April 24, 2025, represents a non-competitive award that leverages the vendor's existing indefinite delivery contract with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $1,176.88 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count) on May 6, 2025, with completion scheduled for May 7, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units, with a contract ceiling value of $1,647.48. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and is scheduled for completion by September 25,...
- The Defense Logistics Agency awarded a delivery order valued at $3,612.72 to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count supply) on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract under the company's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) valued at $2,634.43. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as...
- The Defense Logistics Agency awarded a delivery order valued at $1,773.94 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) on July 23, 2025, with completion scheduled for July 24, 2025. This competitive, non-set-aside award represents a firm fixed-price delivery order fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylphenidate ER 54 mg tablets in quantities of 100 units, valued at $1,279.09. This competitive award, issued without set-aside designation, represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,630.67 to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100-count containers) with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTWLHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 28, 2025, for the supply of Methylphenidate ER 27 mg tablets in a quantity of 100 count at a firm fixed price ceiling value of $1,291.52. This is a non-set-aside competitive award executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The delivery order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and military healthcare systems. The company's extensive portfolio under the DLA Troop Support Medical contract encompasses a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for methylphenidate, a controlled substance commonly prescribed for attention deficit hyperactivity disorder within military and veteran healthcare programs, exemplifies the routine pharmaceutical supply fulfillment that occurs under the broader prime vendor contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/28/25 |